Similarly, Lee et al. demonstrated that iCRT-3, a novel compound that disrupts both β-catenin/TCF and β-catenin/AR protein-protein interactions, inhibited PCa growth in vivo and blocked bicalutamide-resistant prostate sphere-forming cells [268]. Here, HNF4A is linked to posterior cortical atrophy.